Lupin gets EIR from USFDA for Nagpur plant; MD says committed to enhance compliance, quality standards at all sites

Drug maker Lupin on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant in Nagpur

Press Trust of India April 13, 2020 11:41:43 IST
Lupin gets EIR from USFDA for Nagpur plant; MD says committed to enhance compliance, quality standards at all sites

New Delhi: Drug maker Lupin on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant in Nagpur.

Lupin gets EIR from USFDA for Nagpur plant MD says committed to enhance compliance quality standards at all sites

Representational image. Reuters

The US Food and Drug Administration (USFDA) issues an EIR to a company when an inspection is satisfactorily closed.

The health regulator had inspected the company's Nagpur manufacturing facility between 6 January and 10 January, 2020, Lupin Ltd said in a statement.

"We are very happy to have received the EIR for our Nagpur facility, our largest and most advanced oral solid dosage facility. We remain committed to enhancing compliance and quality standards across all our manufacturing sites," Lupin Managing Director Nilesh Gupta said.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Emerging landscape of COVID-19 vaccines in India, as of 5 Aug: Bharat Bio, Zydus candidates move to Phase 2 after clearing test of safety
India

Emerging landscape of COVID-19 vaccines in India, as of 5 Aug: Bharat Bio, Zydus candidates move to Phase 2 after clearing test of safety

Over a dozen Indian companies are in partnership with other firms and institutes to bring a preventive vaccine into global markets by 2021.

India's Wockhardt signs pact with UK to guarantee filling, packaging of purchased COVID-19 vaccines
World

India's Wockhardt signs pact with UK to guarantee filling, packaging of purchased COVID-19 vaccines

The agreement will help UK address a key challenge in supply that vaccine makers are likely to face — shortage of vials to rapidly 'fill and finish' tens of thousands of vaccine doses.

Cipla confirms collaboration with CSIR, IICT, ICMR to develop COVID-19 treatment
India

Cipla confirms collaboration with CSIR, IICT, ICMR to develop COVID-19 treatment

The Mumbai-based firm is also ramping up manufacturing of drugs required to treat COVID-19, like Lopinavir-Ritonavir and Hydroxychloroquine